NOVAVITA THERA

Serial Number 90271366
606

Registration Progress

Application Filed
Oct 22, 2020
Under Examination
Nov 16, 2021
Approved for Publication
Sep 21, 2021
Published for Opposition
Sep 21, 2021
Registered

Basic Information

Serial Number
90271366
Filing Date
October 22, 2020
Published for Opposition
September 21, 2021
Abandonment Date
June 20, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 20, 2022
Classes
044

Rights Holder

Cytotheryx, Inc.

03
Address
PO Box 7193
Rochester, MN 55903

Ownership History

Cytotheryx, Inc.

Original Applicant
03
Rochester, MN

Cytotheryx, Inc.

Owner at Publication
03
Rochester, MN

Legal Representation

Attorney
Cynthia A. Moyer

Application History

36 events
Date Code Type Description
Jun 21, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 20, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 16, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 20, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 20, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 20, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 20, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 20, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 21, 2021 PUBO A PUBLISHED FOR OPPOSITION
Sep 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 19, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Aug 19, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 19, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 19, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2021 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 19, 2021 HSCD I HIDDEN SENSITIVE CONTENT
Aug 19, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Aug 19, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Aug 19, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 19, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Aug 19, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 11, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 11, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 11, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 11, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 11, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CNRT R NON-FINAL ACTION WRITTEN
Feb 11, 2021 GNRT F NON-FINAL ACTION E-MAILED
Feb 11, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 1, 2021 DOCK D ASSIGNED TO EXAMINER
Dec 10, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 044
medical treatment, namely, administering gene therapies in the nature of in vivo and ex vivo vector treatments; medical treatment, namely, administering gene therapies in the nature of lentiviral vector therapies; medical treatment, namely, administering gene therapies in the nature of gene therapies for the treatment of rare diseases; medical treatment, namely, administering gene therapies in the nature of gene therapies for Hereditary Tyrosinemia Type 1; medical treatment, namely, administering gene therapies in the nature of gene therapies for orphan disease; medical treatment, namely, administering gene therapies in the nature of gene therapies for inborn errors of hepatic metabolism
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The words "novavita thera" has no meaning in a foreign language.

Classification

International Classes
044